Eton Pharmaceuticals (ETON) Other financing activities (2018 - 2023)

Eton Pharmaceuticals has disclosed Other financing activities across 5 years of filings, most recently posting -$1000.0 for Q4 2023.

• Other financing activities for Q4 2023 came in at -$1000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $180000.0 (changed N/A YoY), and the FY2024 annual result was $180000.0, changed 0.0% from the prior year.
• Other financing activities came in at -$1000.0 for Q4 2023 at Eton Pharmaceuticals, down from $181000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.0 million in Q3 2021 to a low of -$1000.0 in Q4 2023.
• The 4-year median for Other financing activities is $605000.0 (2019), against an average of $573214.3.
• Peak annual rise in Other financing activities reached 225.45% in 2019, while the deepest fall reached 67.14% in 2019.
• Eton Pharmaceuticals' Other financing activities stood at $501000.0 in 2019, then jumped by 54.29% to $773000.0 in 2020, then grew by 11.64% to $863000.0 in 2021, then plunged by 100.12% to -$1000.0 in 2023.
• The last three Other financing activities figures came in at -$1000.0 (Q4 2023), $181000.0 (Q1 2023), and $863000.0 (Q4 2021), per Business Quant data.